AUD267.96
1.11% today
Australia, Apr 02, 07:10 am CET
ISIN
AU000000COH5
Symbol
COH
Sector

Cochlear Stock price

AUD267.96
+10.25 3.98% 1M
-21.68 7.49% 6M
-19.61 6.82% YTD
-63.06 19.05% 1Y
+51.82 23.98% 3Y
+89.11 49.83% 5Y
+189.63 242.09% 10Y
Australia, Closing price Wed, Apr 02 2025
+2.95 1.11%
ISIN
AU000000COH5
Symbol
COH
Sector

Key metrics

Market capitalization AUD17.29b
Enterprise Value AUD17.15b
P/E (TTM) P/E ratio 46.83
EV/FCF (TTM) EV/FCF 62.43
EV/Sales (TTM) EV/Sales 7.41
P/S ratio (TTM) P/S ratio 7.47
P/B ratio (TTM) P/B ratio 9.26
Dividend yield 1.55%
Last dividend (FY24) AUD4.10
Revenue growth (TTM) Revenue growth 6.35%
Revenue (TTM) Revenue AUD2.31b
EBIT (operating result TTM) EBIT AUD511.20m
Free Cash Flow (TTM) Free Cash Flow AUD274.70m
EPS (TTM) EPS AUD5.66
P/E forward 42.19
P/S forward 7.17
EV/Sales forward 7.11
Show more

Is Cochlear a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Cochlear Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Cochlear forecast:

6x Buy
33%
10x Hold
56%
2x Sell
11%

Analyst Opinions

18 Analysts have issued a Cochlear forecast:

Buy
33%
Hold
56%
Sell
11%

Financial data from Cochlear

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
2,315 2,315
6% 6%
100%
- Direct Costs 574 574
5% 5%
25%
1,741 1,741
7% 7%
75%
- Selling and Administrative Expenses 850 850
8% 8%
37%
- Research and Development Expense 294 294
9% 9%
13%
597 597
4% 4%
26%
- Depreciation and Amortization 86 86
1% 1%
4%
EBIT (Operating Income) EBIT 511 511
5% 5%
22%
Net Profit 371 371
6% 6%
16%

In millions AUD.

Don't miss a Thing! We will send you all news about Cochlear directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Head office Australia
CEO Diggory Howitt
Employees 5,000
Founded 1983
Website www.cochlear.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today